BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 12126877)

  • 1. A 6-hydroxydopamine lesion of the mesostriatal dopamine system decreases the expression of corticotropin releasing hormone and neurotensin mRNAs in the amygdala and bed nucleus of the stria terminalis.
    Day HE; Vittoz NM; Oates MM; Badiani A; Watson SJ; Robinson TE; Akil H
    Brain Res; 2002 Aug; 945(2):151-9. PubMed ID: 12126877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: evidence for their selective activation by interleukin-1beta.
    Day HE; Curran EJ; Watson SJ; Akil H
    J Comp Neurol; 1999 Oct; 413(1):113-28. PubMed ID: 10464374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels.
    Cenci MA; Campbell K; Björklund A
    Neuroscience; 1993 Nov; 57(2):275-96. PubMed ID: 8115038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic cocaine exposure on corticotropin-releasing hormone binding protein in the central nucleus of the amygdala and bed nucleus of the stria terminalis.
    Erb S; Funk D; Borkowski S; Watson SJ; Akil H
    Neuroscience; 2004; 123(4):1003-9. PubMed ID: 14751291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus.
    Makino S; Gold PW; Schulkin J
    Brain Res; 1994 Sep; 657(1-2):141-9. PubMed ID: 7820612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Region-specific regulation of neuropeptide mRNAs in rat limbic forebrain neurones by aldosterone and corticosterone.
    Watts AG; Sanchez-Watts G
    J Physiol; 1995 May; 484 ( Pt 3)(Pt 3):721-36. PubMed ID: 7623287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological stress increased corticotropin-releasing hormone mRNA and content in the central nucleus of the amygdala but not in the hypothalamic paraventricular nucleus in the rat.
    Makino S; Shibasaki T; Yamauchi N; Nishioka T; Mimoto T; Wakabayashi I; Gold PW; Hashimoto K
    Brain Res; 1999 Dec; 850(1-2):136-43. PubMed ID: 10629757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala.
    Day HE; Badiani A; Uslaner JM; Oates MM; Vittoz NM; Robinson TE; Watson SJ; Akil H
    J Neurosci; 2001 Jan; 21(2):732-40. PubMed ID: 11160452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prefrontal corticostriatal afferents maintain increased enkephalin gene expression in the dopamine-denervated rat striatum.
    Campbell K; Björklund A
    Eur J Neurosci; 1994 Aug; 6(8):1371-83. PubMed ID: 7981878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal.
    McNally GP; Akil H
    Neuroscience; 2002; 112(3):605-17. PubMed ID: 12074902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-Fenfluramine induces serotonin-mediated Fos expression in corticotropin-releasing factor and oxytocin neurons of the hypothalamus, and serotonin-independent Fos expression in enkephalin and neurotensin neurons of the amygdala.
    Javed A; Kamradt MC; Van de Kar LD; Gray TS
    Neuroscience; 1999 Mar; 90(3):851-8. PubMed ID: 10218785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that preimmunization with a heat-killed preparation of Mycobacterium vaccae reduces corticotropin-releasing hormone mRNA expression in the extended amygdala in a fear-potentiated startle paradigm.
    Loupy KM; Arnold MR; Hassell JE; Lieb MW; Milton LN; Cler KE; Fox JH; Siebler PH; Schmidt D; Noronha SISR; Day HEW; Lowry CA
    Brain Behav Immun; 2019 Mar; 77():127-140. PubMed ID: 30597198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural regulation of corticotropin releasing hormone (CRH) and CRH receptor mRNA in the hypothalamic paraventricular nucleus in the rat.
    Kiss A; Palkovits M; Aguilera G
    J Neuroendocrinol; 1996 Feb; 8(2):103-12. PubMed ID: 8868257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic characterization of neurotensin messenger RNA-expressing cells in the neuroleptic-treated rat striatum: a detailed cellular co-expression study.
    Augood SJ; Westmore K; Emson PC
    Neuroscience; 1997 Feb; 76(3):763-74. PubMed ID: 9135049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus.
    Makino S; Gold PW; Schulkin J
    Brain Res; 1994 Mar; 640(1-2):105-12. PubMed ID: 8004437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenalectomy decreases corticotropin-releasing hormone gene expression and increases noradrenaline and dopamine extracellular levels in the rat lateral bed nucleus of the stria terminalis.
    Santibañez M; Gysling K; Forray MI
    J Neurosci Res; 2005 Jul; 81(1):140-52. PubMed ID: 15931675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of prodynorphin and corticotrophin-releasing hormone in the rat central amygdala: evidence of two distinct endogenous opioid systems in the lateral division.
    Marchant NJ; Densmore VS; Osborne PB
    J Comp Neurol; 2007 Oct; 504(6):702-15. PubMed ID: 17722034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Region-specific immediate-early gene expression following the administration of corticotropin-releasing hormone in virgin and lactating rats.
    Da Costa AP; Kampa RJ; Windle RJ; Ingram CD; Lightman SL
    Brain Res; 1997 Oct; 770(1-2):151-62. PubMed ID: 9372214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of repeated administration of dopamine agonists on striatal neuropeptide mRNA expression in rats with a unilateral nigral 6-hydroxydopamine lesion.
    Granata R; Wenning GK; Jolkkonen J; Jenner P; Marsden CD
    J Neural Transm (Vienna); 1996; 103(3):249-60. PubMed ID: 8739837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid stress-induced elevations in corticotropin-releasing hormone mRNA in rat central amygdala nucleus and hypothalamic paraventricular nucleus: an in situ hybridization analysis.
    Hsu DT; Chen FL; Takahashi LK; Kalin NH
    Brain Res; 1998 Mar; 788(1-2):305-10. PubMed ID: 9555067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.